Tess Meuleman

419 total citations
17 papers, 310 citations indexed

About

Tess Meuleman is a scholar working on Immunology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Tess Meuleman has authored 17 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Reproductive Medicine and 7 papers in Obstetrics and Gynecology. Recurrent topics in Tess Meuleman's work include Reproductive System and Pregnancy (13 papers), Endometriosis Research and Treatment (6 papers) and Pregnancy and Medication Impact (6 papers). Tess Meuleman is often cited by papers focused on Reproductive System and Pregnancy (13 papers), Endometriosis Research and Treatment (6 papers) and Pregnancy and Medication Impact (6 papers). Tess Meuleman collaborates with scholars based in Netherlands, Finland and United States. Tess Meuleman's co-authors include Frans H.J. Claas, J. M. M. van Lith, Michael Eikmans, Kitty W.M. Bloemenkamp, Eileen Lashley, Olaf M. Dekkers, Marie‐Louise van der Hoorn, K.W.M. Bloemenkamp, Risto Kaaja and Els van Beelen and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and European Journal of Obstetrics & Gynecology and Reproductive Biology.

In The Last Decade

Tess Meuleman

15 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tess Meuleman Netherlands 11 218 117 111 85 41 17 310
P. M. Emmer Netherlands 8 319 1.5× 112 1.0× 66 0.6× 128 1.5× 27 0.7× 9 347
Teddy Mselle Tanzania 8 384 1.8× 69 0.6× 127 1.1× 121 1.4× 24 0.6× 17 456
Shoji Kaku Japan 9 244 1.1× 139 1.2× 168 1.5× 237 2.8× 28 0.7× 24 392
Louise M. Gaynor United Kingdom 6 443 2.0× 88 0.8× 187 1.7× 147 1.7× 23 0.6× 6 484
J. A. Brewster United Kingdom 4 238 1.1× 102 0.9× 121 1.1× 148 1.7× 20 0.5× 6 304
Zs. Faust Hungary 6 379 1.7× 190 1.6× 102 0.9× 182 2.1× 41 1.0× 9 449
O. M. R. Westwood United Kingdom 6 245 1.1× 84 0.7× 71 0.6× 115 1.4× 27 0.7× 8 393
Christina Kruse Denmark 7 368 1.7× 188 1.6× 125 1.1× 163 1.9× 70 1.7× 12 417
Barbara Polese Belgium 9 227 1.0× 55 0.5× 39 0.4× 50 0.6× 20 0.5× 11 316
Jun Kitazawa Japan 10 285 1.3× 118 1.0× 196 1.8× 249 2.9× 35 0.9× 19 440

Countries citing papers authored by Tess Meuleman

Since Specialization
Citations

This map shows the geographic impact of Tess Meuleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tess Meuleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tess Meuleman more than expected).

Fields of papers citing papers by Tess Meuleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tess Meuleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tess Meuleman. The network helps show where Tess Meuleman may publish in the future.

Co-authorship network of co-authors of Tess Meuleman

This figure shows the co-authorship network connecting the top 25 collaborators of Tess Meuleman. A scholar is included among the top collaborators of Tess Meuleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tess Meuleman. Tess Meuleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Al‐Nasiry, Salwan, Marc Spaanderman, Marien I. de Jonge, et al.. (2025). Impact of a moderate-intensity aerobic exercise intervention on systemic and uterine natural killer cells in women with unexplained recurrent pregnancy loss. Frontiers in Immunology. 16. 1602939–1602939.
2.
Feyaerts, Dorien, Marilen Benner, Tess Meuleman, et al.. (2025). Profiling NK cell receptor repertoire of women with idiopathic recurrent pregnancy loss. Journal of Reproductive Immunology. 173. 104803–104803.
3.
Fossé, Nadia A. du, Eileen Lashley, Tess Meuleman, et al.. (2021). Identification of distinct seminal plasma cytokine profiles associated with male age and lifestyle characteristics in unexplained recurrent pregnancy loss. Journal of Reproductive Immunology. 147. 103349–103349. 14 indexed citations
4.
Oosterhuis, Wolter, et al.. (2021). Pathological diagnosis of thoracic endometriosis. BMJ Case Reports. 14(8). e243258–e243258. 4 indexed citations
5.
Eikmans, Michael, Jacqueline D.H. Anholts, Tess Meuleman, et al.. (2020). Optimization of microRNA Acquirement from Seminal Plasma and Identification of Diminished Seminal microRNA-34b as Indicator of Low Semen Concentration. International Journal of Molecular Sciences. 21(11). 4089–4089. 24 indexed citations
6.
Meuleman, Tess, Geert W. Haasnoot, Marise M. Wagner, et al.. (2019). Oral sex is associated with reduced incidence of recurrent miscarriage. Journal of Reproductive Immunology. 133. 1–6. 8 indexed citations
7.
Haasnoot, Geert W., J.J.M. Drabbels, Carin van der Keur, et al.. (2019). Soluble HLA‐G levels in seminal plasma are associated with HLA‐G 3′UTR genotypes and haplotypes. HLA. 94(4). 339–346. 9 indexed citations
8.
Meuleman, Tess, J.J.M. Drabbels, J. M. M. van Lith, et al.. (2018). Lower frequency of the HLA-G UTR-4 haplotype in women with unexplained recurrent miscarriage. Journal of Reproductive Immunology. 126. 46–52. 23 indexed citations
9.
Nederlof, Iris, Tess Meuleman, Marie‐Louise van der Hoorn, Frans H.J. Claas, & Michael Eikmans. (2017). The seed to success: The role of seminal plasma in pregnancy. Journal of Reproductive Immunology. 123. 24–28. 20 indexed citations
10.
Meuleman, Tess, Geert W. Haasnoot, J. M. M. van Lith, et al.. (2017). Paternal HLA‐C is a risk factor in unexplained recurrent miscarriage. American Journal of Reproductive Immunology. 79(2). 17 indexed citations
11.
Meuleman, Tess, et al.. (2016). HLA-C antibodies in women with recurrent miscarriage suggests that antibody mediated rejection is one of the mechanisms leading to recurrent miscarriage. Journal of Reproductive Immunology. 116. 28–34. 30 indexed citations
12.
Meuleman, Tess, et al.. (2015). HLA associations and HLA sharing in recurrent miscarriage: A systematic review and meta-analysis. Human Immunology. 76(5). 362–373. 60 indexed citations
13.
Meuleman, Tess, et al.. (2015). The immunomodulating effect of seminal plasma on T cells. Journal of Reproductive Immunology. 110. 109–116. 29 indexed citations
14.
Meuleman, Tess, et al.. (2015). Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage. Journal of Reproductive Immunology. 113. 54–60. 13 indexed citations
15.
Nooij, Linda S., et al.. (2014). The Optimal Treatment of Severe Hypertension in Pregnancy: Update of the Role of Nicardipine. Current Pharmaceutical Biotechnology. 15(1). 64–69. 8 indexed citations
16.
Meuleman, Tess, Marc H. F. Schreinemacher, Harry van Goor, Erica A. Bakkum, & P. Joep Dörr. (2013). Adhesion awareness: a nationwide survey of gynaecologists. European Journal of Obstetrics & Gynecology and Reproductive Biology. 169(2). 353–359. 10 indexed citations
17.
Lashley, Eileen, Tess Meuleman, & Frans H.J. Claas. (2013). Beneficial or Harmful Effect of Antipaternal Human Leukocyte Antibodies on Pregnancy Outcome? A Systematic Review and Meta‐Analysis. American Journal of Reproductive Immunology. 70(2). 87–103. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026